e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Diffuse parenchymal lung disease I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevation of serum napsin A levels in patients with hypersensitive pneumonia
T. Kumamoto, A. Harumatsu, K. Sakaue, T. Hamada, M. Yamamoto, T. Hamasaki, K. Mizuno, I. Higashimoto, T. Samukawa, H. Inoue (Kagoshima City, Japan)
Source:
Annual Congress 2013 –Diffuse parenchymal lung disease I
Session:
Diffuse parenchymal lung disease I
Session type:
Thematic Poster Session
Number:
2355
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Kumamoto, A. Harumatsu, K. Sakaue, T. Hamada, M. Yamamoto, T. Hamasaki, K. Mizuno, I. Higashimoto, T. Samukawa, H. Inoue (Kagoshima City, Japan). Elevation of serum napsin A levels in patients with hypersensitive pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2355
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Seasonal variation of serum KL-6 levels in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 1
Year: 2014
Serum heat shock protein 47 levels in patients with drug induced lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Elevation of serum napsin A in interstitial lung diseases in comparison with KL-6 and surfactant protein-D
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Usefulness of serum bird specific antibody levels in patients with interstitial pneumonia
Source: International Congress 2016 – Orphan diseases II
Year: 2016
MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Comparative role of serum cathepsin S concentrations for differential diagnosis of sarcoidosis from other lung diseases
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
Serum procalcitonin is useful in differentiating between drug-induced pneumonitis and bacterial pneumonia
Source: International Congress 2014 – ILDs 5
Year: 2014
Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Elevated neutrophil lymphocyte ratio and T4 levels can be predisposing factors for silicosis
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014
KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
The clinical features of 13 patients with interstitial pneumonia with positive anti-glycyl-tRNA synthetase autoantibodies
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept